PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma - Perry, JR; Julian, JA; Laperriere, NJ (J Thromb Haemost, 2010)